Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune response to extracted pollen residues.

N Schramm, R Freiskorn, H Göing

    Arzneimittel-Forschung
    |January 1, 1982
    PubMed
    Summary

    Modified pollen extracts with significantly reduced allergenic activity demonstrate comparable or superior capacity in priming for antibody formation in guinea pigs. This suggests potential for developing safer, effective immunotherapy agents.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Initial performance evaluation of a preclinical PET scanner available as a clip-on assembly in a sequential PET/MRI system.

    Physics in medicine and biology·2018
    Same author

    Tumor response and clinical outcome in metastatic gastrointestinal stromal tumors under sunitinib therapy: comparison of RECIST, Choi and volumetric criteria.

    European journal of radiology·2013
    Same author

    Detection of underlying malignancy in patients with paraneoplastic neurological syndromes: comparison of 18F-FDG PET/CT and contrast-enhanced CT.

    European journal of nuclear medicine and molecular imaging·2013
    Same author

    [Value of magnetic resonance imaging in diffuse liver diseases].

    Der Radiologe·2012
    Same author

    [Importance of PET/CT for imaging of colorectal cancer].

    Der Radiologe·2012
    Same author

    Dual energy CT for monitoring targeted therapies in patients with advanced gastrointestinal stromal tumor: initial results.

    Current pharmaceutical biotechnology·2011

    Area of Science:

    • Immunology
    • Allergen immunotherapy

    Background:

    • Pollen extracts are used for allergy diagnosis and immunotherapy.
    • Native pollen extracts can cause adverse reactions due to high allergenic activity.
    • Modified extracts may offer a safer alternative if their immune-priming capacity is preserved.

    Purpose of the Study:

    • To investigate and measure the immune-priming capacity of modified allergenic preparations.
    • To compare the priming capacity of low-allergenicity extracts with native extracts.
    • To assess the potential of modified extracts for developing safer allergy treatments.

    Main Methods:

    • Guinea pigs were immunized with native pollen extract.
    • Modified pollen residues with reduced allergenic activity were prepared.
    • The capacity of modified extracts to prime for antibody formation against native pollen was assessed.
    • Re-extractable allergenic activity was quantified and compared.

    Main Results:

    • Modified pollen residues showed three to five orders of magnitude less re-extractable allergenic activity.
    • These modified residues exhibited equal or better capacity in priming for antibody formation compared to native extracts.
    • The modification process did not interfere with the immune response against native allergen structures.

    Conclusions:

    • Reduced allergenic activity does not compromise the immune-priming potential of pollen extracts.
    • Modified allergenic preparations warrant further investigation and optimization for immunotherapy.
    • These findings support the development of safer and effective allergy treatments.

    Related Experiment Videos